Developing an abuse-deterrent oral formulation of oxycodone for pain.
Industry: Health Care
First Day Return: +2.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/02/2015 |
Offer Price | $12.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 5.8 |
Deal Size ($mm) | $70 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/06/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $70 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Canton, MA, United States |
Founded | 2002 |
Employees at IPO | 24 |
Website www.collegiumpharma.com |